echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New research shows that some cancer drugs have the potential to treat Alzheimer's disease

    New research shows that some cancer drugs have the potential to treat Alzheimer's disease

    • Last Update: 2022-01-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In a new study, researchers from research institutions such as the National Institute on Aging (NIA) found that existing and emerging cancer drugs may be Therapies for the population to conduct clinical trials


    These authors found changes in brain proteins associated with APOE4 genetic risk variants in young post-mortem study participants (average age of death was 39), and correlated these changes with Alzheimer’s disease patients and non-Alzheimer’s disease The changes in the autopsy brain of patients (average age at death of 89 years) were compared


    This analysis includes brain samples from the Baltimore Longitudinal Study of Aging, the Religious Orders Study, and other NIA-funded research


    Their results showed that an experimental drug for the treatment of liver cancer and Dasatinib, which is approved for chronic myelogenous leukemia, act on some of the proteins related to Alzheimer’s disease, indicating that they may be Potential drugs for the treatment of Alzheimer's disease


    Identify early AD proteome characteristics

    Picture from Science Advances, 2021, doi:10.


    These findings provide evidence for another recent study, demonstrating the value of this data-driven approach in drug reuse research


    Note: The original text has been deleted

    Reference materials:

    Jackson A.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.